1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Enteral supplementation with arachidonic and docosahexaenoic acid and pulmonary outcome in extremely preterm infants
(
- Contribution to journal › Article
-
Mark
Arachidonic acid and docosahexaenoic acid levels correlate with the inflammation proteome in extremely preterm infants
(
- Contribution to journal › Article
- 2023
-
Mark
Visual outcome at 2.5 years of age in ω-3 and ω-6 long-chain polyunsaturated fatty acid supplemented preterm infants : a follow-up of a randomized controlled trial
(
- Contribution to journal › Article
-
Mark
The development of blood protein profiles in extremely preterm infants follows a stereotypic evolution pattern
(
- Contribution to journal › Article
-
Mark
Modification of serum fatty acids in preterm infants by parenteral lipids and enteral docosahexaenoic acid/arachidonic acid : A secondary analysis of the Mega Donna Mega trial
(
- Contribution to journal › Article
- 2022
-
Mark
Fatty acid composition of milk from mothers giving birth at extremely low gestation in Sweden
(
- Contribution to journal › Article
-
Mark
Longitudinal Serum Metabolomics in Extremely Premature Infants : Relationships With Gestational Age, Nutrition, and Morbidities
(
- Contribution to journal › Article
-
Mark
Preterm infant circulating sex steroid levels are not altered by transfusion with adult male plasma : a retrospective multicentre cohort study
(
- Contribution to journal › Article
- 2021
-
Mark
Serum choline in extremely preterm infants declines with increasing parenteral nutrition
(
- Contribution to journal › Article
-
Mark
Decreased Platelet Counts and Serum Levels of VEGF-A, PDGF-BB, and BDNF in Extremely Preterm Infants Developing Severe ROP
(
- Contribution to journal › Article